For the control group, we screened 1377 consecutive NSCLC patients in SYSUCC from 10th Jan 2012 to 25th Apr 2014, 194 advanced both ALK‐ and EGFR‐negative patients were enrolled. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.